MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mutation screening and burden analysis of MED27 in dystonia in a Chinese population

    J. Lin, C. Li, H. Shang (Chengdu, China)

    Objective: We aimed to systematically evaluate the genetic associations of MED27with dystonia in a dystonia cohort. Background: Recently,Meng et alreported a novel neurodevelopmental syndrome manifested homogeneously as…
  • 2022 International Congress

    Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson’s disease genes

    K. Roopnarain, E. Vollstedt,, L. Lange, S. Padmanabhan, C. Blauwendraat, A. Singleton, K. Katja, C. Klein (Luebeck, Germany)

    Objective: To create a global cohort of manifesting and non-manifesting carriers of pathogenic variants in known monogenic Parkinson's disease (PD) genes, such as LRRK2, PRKN, and PINK1, to better…
  • 2022 International Congress

    A systematic review of non-motor symptoms in atypical parkinsonian syndromes

    P. Ananthavarathan, B. Patel, R. Lamb, S. Peroos, N. Malek (London, United Kingdom)

    Objective: We wanted to systematically analyse the repertoire of NMS in patients with progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD) and…
  • 2022 International Congress

    Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

    E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

    Objective: This study aims at exploring the response of the mirror neuron system, specifically motor resonance, to an emotion-enriched context in people with Parkinson disease…
  • 2022 International Congress

    Heart-brain synchronization breakdown in Parkinson’s disease

    M. Iniguez, A. Jimenez-Marin, A. Erramuzpe, M. Acera, B. Tijero, A. Murueta-Goyena, R. Del Pino, T. Fernandez, M. Carmona‑abellan, A. Cabrera, JC. Gomez‑esteban, J. Cortes, I. Gabilondo (Getafe, Spain)

    Objective: To evaluate the alterations in the synchronization between central autonomic network (CAN) activity and a broad set of heart rate variability (HRV) parameters reflecting…
  • 2022 International Congress

    Non-apoptotic caspase-3 activation mediates early synaptic dysfunction of indirect pathway neurons in the parkinsonian striatum

    C. Li, T. Fieblinger, E. Espa, MA. Cenci (Lund, Sweden)

    Objective: We set out to investigate whether caspase-3 plays a role in the loss of dendritic spines and the concomitant synaptic deficits that develop in…
  • 2022 International Congress

    EEG-based Mapping of Resting-state Functional Brain Networks in Patients with Parkinson’s Disease

    L. Maidan, D. Possti, S. Leviashvili, Y. Ezra, D. Amgad, D. Ken, S. Groppa, M. Muthuraman (Tel aviv, Israel)

    Objective: To explore changes in directed functional connectivity in four networks, namely the sensory-motor network (SMN), ventral-attention network (VAN), dorsal-attention network (DAN), and central-executive network…
  • 2022 International Congress

    The Correlation Analyses of Parkinson’s Disease with Serum Homocysteine, Folic Acid and Vitamin B12

    YP. Chen, Y. Qu, JT. Li, Z. Min, YJ. Xiong, Z. Xue (Wuhan, China)

    Objective: To explore the associations of serum homocysteine (Hcy), folic acid (FA) and vitamin B12 (VitB12) levels with the severity of Parkinson's disease (PD), as…
  • 2022 International Congress

    Experience with apomorphine infusion cartridge in France – evaluation of patient and healthcare team benefits

    M. Vérin, M. Demais (Rennes, France)

    Objective: To evaluate ‘real-world’ benefits for patients with Parkinson’s disease (PD) and impact on healthcare team practice of the introduction of apomorphine infusion (APO) cartridge…
  • 2022 International Congress

    Affected tongue movements in idiopathic REM sleep behavior disorder

    T. Thies, N. Geerts, D. Mücke, A. Seger, M. Barbe, M. Sommerauer (Cologne, Germany)

    Objective: In Parkinson’s disease (PD), recognition of speech deviations often follows clinical diagnosis. But what if speech is a prodromal biomarker in PD? The study…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley